new_0222_0333|CRBU|Short Name|0|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|sga_expense|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return
new_0222_0333|CRBU|Long Name|1|1|Caribou Biosciences Inc Total Current Assets (Quarterly) (USD)|Caribou Biosciences Inc Cash and Short Term Investments (Quarterly) (USD)|Caribou Biosciences Inc Inventories (Quarterly) (USD)|Caribou Biosciences Inc Net PP&E (Quarterly) (USD)|Caribou Biosciences Inc Goodwill and Intangibles (Quarterly) (USD)|Caribou Biosciences Inc Total Liabilities (Quarterly) (USD)|Caribou Biosciences Inc Total Current Liabilities (Quarterly) (USD)|Caribou Biosciences Inc Total Long Term Liabilities (Quarterly) (USD)|Caribou Biosciences Inc Total Deposits (Quarterly) (USD)|Caribou Biosciences Inc Book Value (Quarterly) (USD)|Caribou Biosciences Inc Retained Earnings (Quarterly) (USD)|Caribou Biosciences Inc Treasury Stock (Quarterly) (USD)|Caribou Biosciences Inc EV to Revenues|Caribou Biosciences Inc EV to Earnings|Caribou Biosciences Inc EV to Free Cash Flow|Caribou Biosciences Inc EV to Assets (Quarterly)|Caribou Biosciences Inc PS Ratio|Caribou Biosciences Inc PE Ratio|Caribou Biosciences Inc Price to Book Value|Caribou Biosciences Inc PEG Ratio|Caribou Biosciences Inc Debt to Equity Ratio|Caribou Biosciences Inc Dividend Yield|Caribou Biosciences Inc Shareholder Yield (TTM)|Caribou Biosciences Inc Percent of Shares Outstanding Short|Caribou Biosciences Inc Total Receivables (Quarterly) (USD)|Caribou Biosciences Inc Total Payables (Quarterly) (USD)|Caribou Biosciences Inc Total Capital Stock (Quarterly) (USD)|Caribou Biosciences Inc Return on Invested Capital|Caribou Biosciences Inc Quality Ratio Score|Caribou Biosciences Inc Momentum Score|Caribou Biosciences Inc Beta (1Y)|Caribou Biosciences Inc Sustainable Growth Rate (TTM)|Caribou Biosciences Inc Institutional Investor Ownership Percentage|Caribou Biosciences Inc Average Diluted Shares Outstanding (Quarterly)|Caribou Biosciences Inc Total Employees (Annual)|Caribou Biosciences Inc EPS Diluted (Quarterly) (USD)|Caribou Biosciences Inc Shares Outstanding|Caribou Biosciences Inc Repurchase of Capital Stock (Quarterly) (USD)|Caribou Biosciences Inc Ordinary Shares Number (Quarterly)|Caribou Biosciences Inc Payout Ratio|Caribou Biosciences Inc Quick Ratio (Quarterly)|Caribou Biosciences Inc Normalized Diluted EPS (Quarterly) (USD)|Caribou Biosciences Inc Stock Buybacks (Quarterly) (USD)|Caribou Biosciences Inc Effective Tax Rate (TTM)|Caribou Biosciences Inc Return on Equity|Caribou Biosciences Inc Net Income (TTM) (USD)|Caribou Biosciences Inc Revenue (TTM) (USD)|Caribou Biosciences Inc Dividend Per Share (Quarterly) (USD)|Caribou Biosciences Inc Revenue (Quarterly) (USD)|Caribou Biosciences Inc Gross Profit (Quarterly) (USD)|Caribou Biosciences Inc SG&A Expense (Quarterly) (USD)|Caribou Biosciences Inc Pre-Tax Income (Quarterly) (USD)|Caribou Biosciences Inc Net Income (Quarterly) (USD)|Caribou Biosciences Inc Net Interest Income (Quarterly) (USD)|Caribou Biosciences Inc Price (USD)|Caribou Biosciences Inc Total Return Price (USD)|Caribou Biosciences Inc Enterprise Value (USD)|Caribou Biosciences Inc 30-Day Average Daily Volume|Caribou Biosciences Inc 1 Year Price Returns (Daily)
new_0222_0333|CRBU|Unit|2|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric
new_0222_0333|CRBU||4|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|quarterly
new_0222_0333|CRBU||5|5|91|91|0|91|0|91|91|91|0|91|91|0|1.44137931034|0|1.44137931034|0|1.43835616438|0|1.4387755102|0|91|1.44137931034|0|15.4166666667|91|91|91|92|0|0|0|0|30.6666666667|91.3333333333|0|91.3333333333|15.5714285714|0|91|91|91|91.3333333333|91.25|91|0|91|91|0|91.3333333333|0|91.3333333333|91.3333333333|91.3333333333|91.3333333333|1.43835616438|1.43835616438|1.44137931034|1.44827586207|0
new_0222_0333|CRBU||6|6|3|3|0|3|0|3|3|3|0|3|3|0|145|0|145|0|146|0|98|0|3|145|0|12|3|3|3|1|0|0|0|0|6|6|0|6|7|0|3|3|3|6|4|3|0|3|3|0|6|0|6|6|6|6|146|146|145|116|0
new_0222_0333|CRBU||7|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily
new_0222_0333|CRBU|202003|202003|202003||||||||||||||||||||||||||||||||||27.6574||-0.3543||||||-0.3307|||||||1.701||3.489|-11.002|-9.8|0.139|||||
new_0222_0333|CRBU|202006|202006|202006||||||||||||||||||||||||||||||||||27.6574||-0.0677||||||-0.0677|||||||8.478||3.153|-1.922|-1.872|0.006|||||
new_0222_0333|CRBU|202009|202009|202009||||||||||||||||||||||||||||||||||27.6574||-0.2868||||||-0.2868|0||||||1.198||3.247|-8.146|-7.933|-0.002|||||
new_0222_0333|CRBU|202012|202012|202012|24.306|15.953||3.502||18.16|12.389|5.771||-23.437|-30.871||||||||||0.0882||||5.16|2.606|41.324|||||||27.6574||-0.5316|||54.7092|0|1.7042|-0.5316||5.035||-34.308|12.361||0.984||4.173|-15.057|-14.703|0.073|||||
new_0222_0333|CRBU|202103|202103|202103|155.925|145.924||3.38||53.504|22.21|31.294||-35.689|-44.03||||||||||0.0138||||5.825|3.122|150.151|||||||27.6574||-0.48|||54.7092|0|6.8325|-0.48||1.6116||-37.667|12.246||1.586||4.596|-13.159|-13.159|-0.001|||||
new_0222_0333|CRBU|202106|202106|202106|142.967|129.524||4.408||55.938|26.007|29.931||-47.691|-58.341||||||||||0||||8.407|4.034|150.151|-63.1681||||||54.7092||-0.2616|||54.7092|0|5.3036|-0.2905||1.1189||-50.106|5.244||1.476||5.113|-14.311|-14.311|0.044|||||
new_0222_0333|CRBU|202107|202106|202106|||||||||||||179.1219||-66.8552||106.3329|||||0||0.7569|||||||||17.0766||76||56.7092||||||||||||||||||16.2|16.2|939.315||
new_0222_0333|CRBU|202108|202106|202106|||||||||||||314.9946||-117.5681||178.5343|||||0||1.6694|||||||||15.907||||59.9708||||||||||||||||||27.2|27.2|1651.8318||
new_0222_0333|CRBU|202109|202109|202109|449.047|435.31||4.477||57.559|26.158|31.401||404.401|-79.315||124.3174|-15.7949|-44.843|2.1591|115.9684||3.5428||0|0|-22.4065|2.753|7.785|3.482|0.006|-39.3215||||-84.8796|65.9808|45.8896||-0.46|60.0213||60.0213|0|16.9392|-0.4076|-321.02|0.5575|-84.8796|-63.147|8.023||3.977||6.76|-20.974|-20.974|0.022|23.87|23.87|997.3984|863955.4667|
new_0222_0333|CRBU|202110|202109|202109|||||||||||||111.1506||-40.0936||107.4178||3.2816|||0||1.9258|||||||||65.6548||||||||||||||||||||||22.11|22.11|891.7609|500995.7333|
new_0222_0333|CRBU|202111|202109|202109|||||||||||||85.2127||-30.7374||90.3164||2.767|||0||3.2015|||||||||66.0107||||60.1921||||||||||||||||||18.59|18.59|683.6611|342785.7667|
new_0222_0333|CRBU|202112|202112|202112|||||||||||||58.9541||-21.2656||73.3123||2.246|||0||4.3884|||||||||66.9579||||||||||||||||||||||15.09|15.09|472.9888|415289.8|
new_0222_0333|CRBU|202201|202112|202112|||||||||||||26.2435||-9.4664||52.1299||1.5971|||0||4.993|||||||||67.4546||||||||||||||||||||||10.73|10.73|210.5512|540835.9667|
new_0222_0333|CRBU|202202|202112|202112|||||||||||||22.4172||-8.0862||47.6603||1.4602|||0|||||||||||||||||||||||||||||||||9.81|9.81|179.8533|583830.7667|